eslicarbazepine acetate has been researched along with Epilepsy, Temporal Lobe in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dipper-Wawra, M; Fidzinski, P; Holtkamp, M; Kraus, L; Maier, N; Monni, L; Schmitz, D; Soares-da-Silva, P | 1 |
| Loureiro, A; Pekcec, A; Potschka, H; Soares-da-Silva, P; Soerensen, J | 1 |
2 other study(ies) available for eslicarbazepine acetate and Epilepsy, Temporal Lobe
| Article | Year |
|---|---|
In vitro and in vivo anti-epileptic efficacy of eslicarbazepine acetate in a mouse model of KCNQ2-related self-limited epilepsy.
Topics: Animals; Anticonvulsants; Dibenzazepines; Epilepsy; Epilepsy, Temporal Lobe; KCNQ2 Potassium Channel; Mice; Seizures | 2022 |
Effect of eslicarbazepine acetate in the corneal kindling progression and the amygdala kindling model of temporal lobe epilepsy.
Topics: Amygdala; Animals; Anticonvulsants; Cornea; Dibenzazepines; Dose-Response Relationship, Drug; Epilepsy, Temporal Lobe; Female; Kindling, Neurologic; Male; Mice | 2014 |